Business Segments · Total operating earnings
Pharmaceutical and Specialty Solutions — Total operating earnings
Cardinal Health Pharmaceutical and Specialty Solutions — Total operating earnings increased by 14.1% to $784.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 18.4%, from $662.00M to $784.00M. Over 2 years (FY 2022 to FY 2025), Pharmaceutical and Specialty Solutions — Total operating earnings shows an upward trend with a 17.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementSegment
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ3 2021
Last reportedQ1 2026
Rolls up toOperating Income
How to read this metric
Higher earnings indicate strong operational performance and effective cost control.
Detailed definition
The profit generated by the Pharmaceutical and Specialty Solutions segment after deducting all operating costs and expen...
Peer comparison
The primary metric for comparing segment-level profitability against industry peers.
Metric ID:
cah_segment_pharmaceutical_and_specialty_solutions_total_operating_earningsHistorical Data
16 periods
| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q1 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $410.75M | $410.75M | $410.75M | $410.75M | $560.00M | $456.00M | $495.00M | $580.00M | $484.00M | $530.00M | $531.00M | $662.00M | $535.00M | $667.00M | $687.00M | $784.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +36.3% | -18.6% | +8.6% | +17.2% | -16.6% | +9.5% | +0.2% | +24.7% | -19.2% | +24.7% | +3.0% | +14.1% |
| YoY Change | — | — | — | — | +36.3% | — | — | +3.6% | — | +16.2% | +7.3% | +14.1% | +10.5% | +25.8% | +29.4% | +18.4% |
Range$410.75M – $784.00M
CAGR+18.8%
Avg YoY Growth+18.0%
Median YoY Growth+16.2%
Current Streak3 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Cardinal Health's pharmaceutical and specialty solutions — total operating earnings?
- Cardinal Health (CAH) reported pharmaceutical and specialty solutions — total operating earnings of $784.00M in Q1 2026.
- How has Cardinal Health's pharmaceutical and specialty solutions — total operating earnings changed year-over-year?
- Cardinal Health's pharmaceutical and specialty solutions — total operating earnings increased by 18.4% year-over-year, from $662.00M to $784.00M.
- What is the long-term trend for Cardinal Health's pharmaceutical and specialty solutions — total operating earnings?
- Over 2 years (2022 to 2025), Cardinal Health's pharmaceutical and specialty solutions — total operating earnings has grown at a 17.2% compound annual growth rate (CAGR), from $1.64B to $2.26B.
- What does pharmaceutical and specialty solutions — total operating earnings mean?
- The operating profit earned by the pharmaceutical and specialty solutions segment.